3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to limited evidence suggesting different pharmacological actions. Present studies indicate that https://www.pinterest.com/pin/1140888518124046392/